These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24022796)

  • 21. Who says "no" to participating in stroke clinical trials and why: an observational study from the Vancouver Stroke Program.
    O'Neill ZR; Deptuck HM; Quong L; Maclean G; Villaluna K; King-Azote P; Sharma M; Butcher K; Hart RG; Field TS
    Trials; 2019 May; 20(1):313. PubMed ID: 31151483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parental Factors Associated With the Decision to Participate in a Neonatal Clinical Trial.
    Weiss EM; Olszewski AE; Guttmann KF; Magnus BE; Li S; Shah AR; Juul SE; Wu YW; Ahmad KA; Bendel-Stenzel E; Isaza NA; Lampland AL; Mathur AM; Rao R; Riley D; Russell DG; Salih ZNI; Torr CB; Weitkamp JH; Anani UE; Chang T; Dudley J; Flibotte J; Havrilla EM; Kathen CM; O'Kane AC; Perez K; Stanley BJ; Wilfond BS; Shah SK
    JAMA Netw Open; 2021 Jan; 4(1):e2032106. PubMed ID: 33433595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment rates and reasons for community physicians' non-participation in an interdisciplinary intervention study on leg ulceration.
    Herber OR; Schnepp W; Rieger MA
    BMC Med Res Methodol; 2009 Aug; 9():61. PubMed ID: 19682354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.
    Klerk CP; Smorenburg SM; Büller HR
    Arch Intern Med; 2003 Sep; 163(16):1913-21. PubMed ID: 12963564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.
    Lassen MR; Borris LC; Anderson BS; Jensen HP; Skejø Bro HP; Andersen G; Petersen AO; Siem P; Hørlyck E; Jensen BV; Thomsen PB; Hansen BR; Erin-Madsen J; Møller JC; Rotwitt L; Christensen F; Nielsen JB; Jørgensen PS; Paaske B; Tørholm C; Hvidt P; Jensen NK; Nielsen AB; Appelquist E; Tjalve E
    Thromb Res; 1998 Mar; 89(6):281-7. PubMed ID: 9669750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis.
    Cook D; Sinuff T; Zytaruk N; Rabbat C; Lee A; O'Donnell M; Thabane L; Linkins L; Treleaven D; Patel R; Meade M; Crowther M; Marshall JC; Douketis J;
    J Crit Care; 2009 Jun; 24(2):168-75. PubMed ID: 19327956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dalteparin versus unfractionated heparin in critically ill patients.
    ; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
    N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.
    Rodger MA; Hague WM; Kingdom J; Kahn SR; Karovitch A; Sermer M; Clement AM; Coat S; Chan WS; Said J; Rey E; Robinson S; Khurana R; Demers C; Kovacs MJ; Solymoss S; Hinshaw K; Dwyer J; Smith G; McDonald S; Newstead-Angel J; McLeod A; Khandelwal M; Silver RM; Le Gal G; Greer IA; Keely E; Rosene-Montella K; Walker M; Wells PS;
    Lancet; 2014 Nov; 384(9955):1673-83. PubMed ID: 25066248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.
    Logan JK; Tang C; Liao Z; Lee JJ; Heymach JV; Swisher SG; Welsh JW; Zhang J; Lin SH; Gomez DR
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):770-777. PubMed ID: 28244413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family and physician influence on asthma research participation decisions for adolescents: the effects of adolescent gender and research risk.
    Brody JL; Scherer DG; Annett RD; Turner C; Dalen J
    Pediatrics; 2006 Aug; 118(2):e356-62. PubMed ID: 16882778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focus group interviews examining attitudes toward medical research among the Japanese: a qualitative study.
    Asai A; Ohnishi M; Nishigaki E; Sekimoto M; Fukuhara S; Fukui T
    Bioethics; 2004 Sep; 18(5):448-70. PubMed ID: 15462026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin.
    Gates S; Brocklehurst P; Ayers S; Bowler U;
    Am J Obstet Gynecol; 2004 Oct; 191(4):1296-303. PubMed ID: 15507957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing the informed consent process for critical care research: strategies from a thromboprophylaxis trial.
    Smith OM; McDonald E; Zytaruk N; Foster D; Matte A; Clarke F; Fleury S; Krause K; McArdle T; Skrobik Y; Cook DJ
    Intensive Crit Care Nurs; 2013 Dec; 29(6):300-9. PubMed ID: 23871290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring patients' reasons for declining contact in a cognitive behavioural therapy randomised controlled trial in primary care.
    Barnes M; Wiles N; Morrison J; Kessler D; Williams C; Kuyken W; Lewis G; Turner K
    Br J Gen Pract; 2012 May; 62(598):e371-7. PubMed ID: 22546597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient and Physician Views about Protocolized Dialysis Treatment in Randomized Trials and Clinical Care.
    Kraybill A; Dember LM; Joffe S; Karlawish J; Ellenberg SS; Madden V; Halpern SD
    AJOB Empir Bioeth; 2016; 7(2):106-115. PubMed ID: 27833931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outpatient treatment of pulmonary embolism with dalteparin.
    Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
    Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. End-of-life care in the pediatric intensive care unit: attitudes and practices of pediatric critical care physicians and nurses.
    Burns JP; Mitchell C; Griffith JL; Truog RD
    Crit Care Med; 2001 Mar; 29(3):658-64. PubMed ID: 11373439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study.
    Crowley ST; Chertow GM; Vitale J; O'Connor T; Zhang J; Schein RM; Choudhury D; Finkel K; Vijayan A; Paganini E; Palevsky PM;
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):955-61. PubMed ID: 18385390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Who refuses enrollment in cardiac clinical trials?
    Sen Biswas M; Newby LK; Bastian LA; Peterson ED; Sugarman J
    Clin Trials; 2007; 4(3):258-63. PubMed ID: 17715252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.